Research Groups

The K.G. Jebsen Colorectal Cancer Research Centre was officially opened on the 28th of August 2014 by the chair of the Jebsen Foundation’s board of directors, Hans Peter Jebsen. Prof. Ragnhild A. Lothe leads the Centre together with the interdisciplinary PI team consisting of Prof. Arild Nesbakken, Prof. Guro E. Lind, Dr. Marianne G. Guren, and Prof. Rolf I. Skotheim.

The centre has five Principal Investigators:

Centre Leader, Prof. Ragnhild A. Lothe, Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital (OUH) and Institute for Clinical Medicine, University of Oslo (UiO) 2014_Åpning Jebsen Senter for Tarmkreft_Ragnhild Lothe9-XL
Prof. Guro E. Lind, Department of Molecular Oncology, Institute for Cancer Research, OUH
Prof. Arild Nesbakken, Department of Gastrointestinal Surgery, OUH and Institute for Clinical Medicine, UiO 2014_Åpning Jebsen Senter for Tarmkreft_Arild Nesbakken2-XL
Dr. Rolf I. Skotheim, Department of Molecular Oncology, Institute for Cancer Research, OUH 2014_Åpning Jebsen Senter for Tarmkreft_Rolf Skotheim1_2-2-XL
Dr. Marianne G. Guren, Department of Oncology, OUH

Latest publications

Majano et al., 2019. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study. Lancet Oncology 20: 74–87 Kryeziu et al., 2019. Combination therapies with HSP90 inhibitors against colorectal cancer. BBA Reviews on Cancer, 1871(2): 240-247 Eilertsen IA et al., 2019. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer. Int J Cancer, 144(4): 841-847 Thomsen et al., 2018. Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome. Br J Cancer 118(12):1609-1616 Mezheyeuski et al., 2018. Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer. Virchows Arch, 472(3): 395-405 All publications